Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of systemic chronic inflammation

LJH Rasmussen, JEV Petersen… - Frontiers in …, 2021 - frontiersin.org
Systemic chronic inflammation (SCI) is persistent, health-damaging, low-grade inflammation
that plays a major role in immunosenescence and in development and progression of many …

Carotid stiffness, intima–media thickness and aortic augmentation index among adults with SARS‐CoV‐2

RE Szeghy, VM Province, NL Stute… - Experimental …, 2022 - Wiley Online Library
New Findings What is the central question of this study? We sought to investigate whether
carotid stiffness, carotid intima–media thickness and the aortic augmentation index are …

[HTML][HTML] Six-month longitudinal tracking of arterial stiffness and blood pressure in young adults following SARS-CoV-2 infection

RE Szeghy, NL Stute, VM Province… - Journal of Applied …, 2022 - journals.physiology.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can increase arterial
stiffness 3–4 wk following infection, even among young, healthy adults. However, the long …

The clinical value of suPAR in diagnosis and prediction for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

Q Huang, H Xiong, T Shuai, Y Wang… - Therapeutic …, 2020 - journals.sagepub.com
Background: Soluble urokinase-type plasminogen activator receptor (suPAR) is positively
correlated with immune system activity. Inflammation can promote the development of …

Association between serum soluble urokinase-type plasminogen activator receptor level and arterial stiffness in chronic hemodialysis patients

WC Lin, TJ Wu, CH Wang, YJ Hsieh… - Journal of Personalized …, 2023 - mdpi.com
Cardiovascular diseases (CVDs) remain a significant cause of death in hemodialysis (HD)
patients. To explore their associations, we examine the role of soluble urokinase-type …

Association between cardiovascular disease-and inflammation-related serum biomarkers and poor lung function in elderly

K Egervall, A Rosso, S Elmståhl - Clinical Proteomics, 2021 - Springer
Background Cardiovascular disease (CVD) is a common comorbidity in chronic obstructive
pulmonary disease (COPD) and reduced lung function is an important risk factor for CVD …

Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease

A Ismail, SS Hayek - Current Cardiology Reports, 2023 - Springer
Abstract Purpose of Review Chronic inflammation is a major contributor to cardiovascular
disease (CVD) risk. Soluble urokinase plasminogen activator receptor (suPAR) is an …

High suPAR and low blood eosinophil count are risk factors for hospital readmission and mortality in patients with COPD

KEJ Håkansson, CS Ulrik, NS Godtfredsen… - … Journal of Chronic …, 2020 - Taylor & Francis
Introduction The biomarker soluble urokinase plasminogen activator receptor (suPAR) has
been associated with increased mortality in chronic obstructive pulmonary disease (COPD) …

Serum levels of biomarkers that may link chronic obstructive pulmonary disease and depressive disorder

E Małujło-Balcerska, T Pietras, W Śmigielski - Pharmacological Reports, 2023 - Springer
Background Depressive disorder is a common comorbidity of chronic obstructive pulmonary
disease (COPD); according to some studies, it occurs in approximately 80% of patients. The …

Association of chronic inflammation with cardiovascular risk in chronic obstructive pulmonary disease—A cross‐sectional study

Đ Ljubičić, V Balta, D Dilber, H Vražić… - Health science …, 2022 - Wiley Online Library
Background and Aims COPD is progressive lung disease with known higher cardiovascular
(CV) risk, mainly attributed to smoking of cigarettes as the main etiological factor of disease …